Xilio Therapeutics, Inc. XLO
Set alert
8.03 USD +0.10 +1.26%
At close · Oct 30
8.03 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
7.05 Day range 8.09
7.14 52-week range 11.90
- YTD
- -10.38%
- 1 year
- -28.69%
- Open
- 7.05
- Prev close
- 7.93
- Mkt cap
- 52.84M
- Vol
- 7.91K
- Avg vol
- 12.46K
- EPS
- -0.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.05
- High
- 8.09
- Forward P/E
- -1.91
- Beta
- -0.20
- Short ratio
- 0.42
- Inst. own
- 29.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.01
- 200-d avg
- 0.970715
- 1y target
- 4.50
Financial health
Altman Z-Score
-2.74 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E -2.1×
FY 2019 5y median -0.9× FY 2025
P/S 1.7×
FY 2019 5y median 0.0× FY 2025
P/B 2.1×
FY 2019 5y median 0.7× FY 2025
P/FCF -13.6×
FY 2019 5y median -1.1× FY 2025
EV/EBITDA 1.7×
FY 2019 5y median 0.3× FY 2025
EV/Sales -1.3×
FY 2019 5y median 0.0× FY 2025
FCF Yield -7.4%
FY 2019 5y median -91.2% FY 2025
Profitability
Gross Margin 96.5%
FY 2019 5y median 0.0% FY 2025
Operating Margin -95.9%
FY 2019 5y median 0.0% FY 2025
Net Margin -80.1%
FY 2019 5y median 0.0% FY 2025
ROE -99.3%
FY 2019 5y median -99.3% FY 2025
ROIC -42.1%
FY 2019 5y median -71.0% FY 2025
ROA -22.6%
FY 2019 5y median -63.4% FY 2025
Growth (YoY)
Revenue 589.9%
FY 2019 FY 2025
Operating Income 30.7%
FY 2019 FY 2025
EPS (diluted) 72.5%
FY 2019 FY 2025
Free Cash Flow 70.1%
FY 2019 FY 2025
Financial Health
Current Ratio 2.6×
FY 2019 5y median 3.0× FY 2025
Quick Ratio 2.6×
FY 2019 5y median 3.0× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 3.9×
FY 2019 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31